SEC Tracker
Get the app

Goodness Growth Holdings VREOF

Goodness Growth Holdings Announces Fourth Quarter and Full Year 2022 Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Reports quarterly results (2.02)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Changes shareholder rights (3.03)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Goodness Growth Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025